Pregled bibliografske jedinice broj: 1058451
Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine
Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine // Journal of clinical medicine, 7 (2018), 9; E291, 36 doi:10.3390/jcm7090291 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1058451 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Dystrophin Cardiomyopathies: Clinical
Management, Molecular Pathogenesis and
Evolution towards Precision Medicine
Autori
D’Amario, Domenico ; Gowran, Aoife ; Canonico, Francesco ; Castiglioni, Elisa ; Rovina, Davide ; Santoro, Rosaria ; Spinelli, Pietro ; Adorisio, Rachele ; Amodeo, Antonio ; Perrucci, Gianluca ; Borovac, Josip Anđelo ; Pompilio, Giulio ; Crea, Filippo
Izvornik
Journal of clinical medicine (2077-0383) 7
(2018), 9;
E291, 36
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Duchenne muscular dystrophy ; cardiomyopathy ; cardiomyopathy in muscular dystrophy ; dilated ; dystrophin ; heart failure ; personalized medicine
Sažetak
Duchenne's muscular dystrophy is an X-linked neuromuscular disease that manifests as muscle atrophy and cardiomyopathy in young boys. However, a considerable percentage of carrier females are often diagnosed with cardiomyopathy at an advanced stage. Existing therapy is not disease-specific and has limited effect, thus many patients and symptomatic carrier females prematurely die due to heart failure. Early detection is one of the major challenges that muscular dystrophy patients, carrier females, family members and, research and medical teams face in the complex course of dystrophic cardiomyopathy management. Despite the widespread adoption of advanced imaging modalities such as cardiac magnetic resonance, there is much scope for refining the diagnosis and treatment of dystrophic cardiomyopathy. This comprehensive review will focus on the pertinent clinical aspects of cardiac disease in muscular dystrophy while also providing a detailed consideration of the known and developing concepts in the pathophysiology of muscular dystrophy and forthcoming therapeutic options.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Emerging Sources Citation Index (ESCI)
- Scopus